Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$4.46
-4.1%
$4.62
$3.18
$6.98
$20.19M-0.94114,020 shs1,253 shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.93
-1.4%
$8.18
$5.37
$17.58
$473.40M1.761.33 million shs859,881 shs
GT Gold Corp. stock logo
GTT
GT Gold
C$3.85
+13.2%
C$3.85
C$1.11
C$4.80
C$501.42MN/A261,805 shs7,092 shs
Corvus Gold Inc. stock logo
KOR
Corvus Gold
C$0.00
C$2.17
C$4.15
C$519.44MN/A239,805 shs115,365 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-1.49%-4.37%+1.58%-6.06%-12.68%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
+1.79%-2.43%-20.87%-22.01%-35.96%
GT Gold Corp. stock logo
GTT
GT Gold
0.00%0.00%0.00%0.00%0.00%
Corvus Gold Inc. stock logo
KOR
Corvus Gold
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$4.46
-4.1%
$4.62
$3.18
$6.98
$20.19M-0.94114,020 shs1,253 shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.93
-1.4%
$8.18
$5.37
$17.58
$473.40M1.761.33 million shs859,881 shs
GT Gold Corp. stock logo
GTT
GT Gold
C$3.85
+13.2%
C$3.85
C$1.11
C$4.80
C$501.42MN/A261,805 shs7,092 shs
Corvus Gold Inc. stock logo
KOR
Corvus Gold
C$0.00
C$2.17
C$4.15
C$519.44MN/A239,805 shs115,365 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-1.49%-4.37%+1.58%-6.06%-12.68%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
+1.79%-2.43%-20.87%-22.01%-35.96%
GT Gold Corp. stock logo
GTT
GT Gold
0.00%0.00%0.00%0.00%0.00%
Corvus Gold Inc. stock logo
KOR
Corvus Gold
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.00
SellN/AN/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.50
Reduce$7.001.01% Upside
GT Gold Corp. stock logo
GTT
GT Gold
0.00
N/AN/AN/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CCM, KOR, DNA, and GTT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
Reiterated RatingSell (E+)
8/17/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
UpgradeHold
8/7/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
DowngradeBuyHold$12.00 ➝ $9.00
7/17/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
Reiterated RatingSell (D-)
(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$65.85M0.29$1.78 per share2.50$60.94 per share0.07
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$170.15M2.74N/AN/A$6.24 per share1.11
GT Gold Corp. stock logo
GTT
GT Gold
N/AN/AC$0.09 per share45.29C$0.10 per shareN/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
N/AN/AN/A99.76C($0.03) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$13.27MN/AN/AN/AN/AN/AN/AN/A9/25/2026 (Estimated)
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$312.76M-$5.01N/AN/AN/A-259.96%-60.27%-26.88%11/5/2026 (Estimated)
GT Gold Corp. stock logo
GTT
GT Gold
N/A-C$0.08N/AN/AN/AN/AN/AN/AN/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
N/A-C$0.20N/AN/AN/AN/AN/AN/AN/A

Latest CCM, KOR, DNA, and GTT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.8950-$0.75+$0.1450-$0.75$24.05 million$20.16 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/AN/AN/AN/AN/A
GT Gold Corp. stock logo
GTT
GT Gold
N/AN/AN/AN/AN/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
C$0.70N/AN/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.33
0.48
0.46
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/A
4.57
4.57
GT Gold Corp. stock logo
GTT
GT Gold
N/A
4.59
4.39
Corvus Gold Inc. stock logo
KOR
Corvus Gold
190.89
0.39
0.36

Institutional Ownership

CompanyInstitutional Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
78.63%
GT Gold Corp. stock logo
GTT
GT Gold
N/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
N/A

Insider Ownership

CompanyInsider Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
12.69%
GT Gold Corp. stock logo
GTT
GT Gold
N/A
Corvus Gold Inc. stock logo
KOR
Corvus Gold
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
9704.34 million2.32 millionNot Optionable
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
64067.34 million58.80 millionOptionable
GT Gold Corp. stock logo
GTT
GT Gold
6,300130.24 millionN/ANot Optionable
Corvus Gold Inc. stock logo
KOR
Corvus Gold
2127.00 millionN/ANot Optionable

Recent News About These Companies

Comex Gold Settles 0.46% Lower at $2073.90
Ladies Michael Kors Ritz Chronograph Watch
Gold Falls Slightly; Fed Moves in Focus
Mens Michael Kors Watches
Corvus Gold Inc (KOR)
Corvus Gold Reports 2021 Annual General Meeting Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Concord Medical Services stock logo

Concord Medical Services NYSE:CCM

$4.46 -0.19 (-4.09%)
As of 03:59 PM Eastern

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Ginkgo Bioworks stock logo

Ginkgo Bioworks NYSE:DNA

$6.93 -0.10 (-1.42%)
As of 03:58 PM Eastern

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

GT Gold stock logo

GT Gold CVE:GTT

C$3.85 +0.45 (+13.24%)
As of 06/3/2021

GT Gold Corp. primarily engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, and copper. Its flagship property is the Tatogga property, which covers an area of approximately 47,500.29 hectares located in the northwestern British Columbia. The company was incorporated in 2013 and is headquartered in Vancouver, Canada. As of May 17, 2021, GT Gold Corp. operates as a subsidiary of Newmont Corporation.

Corvus Gold stock logo

Corvus Gold TSE:KOR

Corvus Gold Inc. acquires, explores, and develops mineral properties primarily in Canada and the United States. Its principal mineral property is the North Bullfrog Project, a gold and silver mining project that consists of patented and unpatented mining claims covering an area of approximately 12,895 hectares located in northwestern Nye County, Nevada. The company was incorporated in 2010 and is headquartered in Vancouver, Canada.